Dare Bioscience, Inc. Finance Lease, Right-of-Use Asset, Amortization
Dare Bioscience, Inc. (DARE) reported Finance Lease, Right-of-Use Asset, Amortization of $436.19 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-13
- Dare Bioscience, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $436.19K, a 3.06% decline year-over-year.
- Dare Bioscience, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $436.19K, a 190.81% increase year-over-year.
- Dare Bioscience, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $425.37K.
- Dare Bioscience, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $449.00K.
- Dare Bioscience, Inc. finance lease, right-of-use asset, amortization for fiscal 2025 was $1.47M.
- Dare Bioscience, Inc. finance lease, right-of-use asset, amortization for fiscal 2024 was $0.00.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 3 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 6 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $436.19K 10-Q · filed 2026-08-13 | $872.39K 10-Q · filed 2026-08-13 | $1.30M derived: sum of 3 quarters · filed 2026-08-13 | $1.75M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $436.19K 10-Q · filed 2026-05-14 | $861.56K derived: sum of 2 quarters · filed 2026-05-14 | $1.31M derived: sum of 3 quarters · filed 2026-05-14 | $1.76M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | $425.37K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $874.37K derived: sum of 2 quarters · filed 2026-03-26 | $1.32M derived: sum of 3 quarters · filed 2026-08-13 | $1.47M 10-K · filed 2026-03-26 | ||
| 2025-09-30 | $449.00K 10-Q · filed 2025-11-13 | $898.98K derived: sum of 2 quarters · filed 2026-08-13 | $1.05M 10-Q · filed 2025-11-13 | $1.05M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $449.98K 10-Q · filed 2026-08-13 | $450.00K 10-Q · filed 2025-08-14 | $599.98K 10-Q · filed 2026-08-13 | $600.00K 10-Q · filed 2025-08-14 | $599.98K derived: sum of 3 quarters · filed 2026-08-13 | $599.98K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $149.99K 10-Q · filed 2026-05-14 | $150.00K 10-Q · filed 2025-05-13 | $149.99K derived: sum of 2 quarters · filed 2026-05-14 | $149.99K derived: sum of 3 quarters · filed 2026-05-14 | $149.99K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $0.00 derived: sum of 3 quarters · filed 2026-03-26 | $0.00 10-K · filed 2026-03-26 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |